Search Results - G. Rodriguez Macias

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    P582: FIRST RESULTS OF A PHASE II STUDY (STIMULUS-AML1) INVESTIGATING SABATOLIMAB + AZACITIDINE + VENETOCLAX IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA by A. M. Zeidan, J. Westermann, T. Kovacsovics, S. Assouline, A. C. Schuh, H.-J. Kim, G. Rodriguez Macias, D. Sanford, M. R. Luskin, E. M. Stein, K. Malek, J. Lyu, M. Stegert, J. Esteve

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    S197: NAVITOCLAX PLUS RUXOLITINIB IN JAK INHIBITOR-NAÏVE PATIENTS WITH MYELOFIBROSIS: PRELIMINARY SAFETY AND EFFICACY IN A MULTICENTER, OPEN-LABEL PHASE 2 STUDY by F. Passamonti, J. Foran, A. Tandra, V. De Stefano, M. Laura Fox, A. Mattour, M. F. McMullin, A. C. Perkins, G. Rodriguez-Macías, H. Sibai, Q. Qin, J. Potluri, J. How

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    P391: FLT3-ITD MEASUREMENT AT DIAGNOSIS AND FOR THE ASSESSMENT OF MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID L... by D. Carbonell, M. Chicano, A. Cardero-Illán, G. Rodriguez-Macías, P. Muñiz, R. Bailén, G. Oarbeascoa, I. Gómez-Centurión, J. Anguita, M. Kwon, J. L. Díez-Martín, I. Buño, C. Martínez-Laperche

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  4. 4

    P573: PHARMACOKINETIC EXPOSURE EQUIVALENCE AND PRELIMINARY EFFICACY AND SAFETY FROM A RANDOMIZED CROSS OVER PHASE 3 STUDY OF AN ORAL HYPOMETHYLATING AGENT DEC-C COMPARED TO IV DECI... by K. Geissler, Z. Koristek, T. Bernal del Castillo, J. Novák, G. Rodriguez Macias, S. K. Metzelder, A. Illes, A. Nagy, J. Mayer, M. Arnan, M.-M. Keating, J. Krauter, M. Lunghi, N. Stefano Fracchiolla, U. Platzbecker, V. Santini, Y. Sano, A. Oganesian, H. Keer, M. Lübbert

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: